Benjamin L. Ebert
Benjamin L. Ebert
| Nationality | American |
|---|---|
| Known for | Research on myelodysplastic syndromes (MDS) |
Benjamin L. Ebert is a prominent American physician-scientist known for his groundbreaking research in the field of hematology and oncology, particularly in the study of myelodysplastic syndromes (MDS). He is a professor at Harvard Medical School and serves as the Chair of Medical Oncology at Dana-Farber Cancer Institute.
Early Life and Education[edit | edit source]
Benjamin L. Ebert was born in the United States. He completed his undergraduate studies at Brown University, where he earned a Bachelor of Science degree. Ebert was a Rhodes Scholar at the University of Oxford, where he obtained a D.Phil. in Molecular Biology. He then attended Harvard Medical School, where he received his M.D. degree.
Career[edit | edit source]
Ebert completed his residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology/oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital. He joined the faculty at Harvard Medical School, where he has made significant contributions to the understanding of hematologic malignancies.
Research[edit | edit source]
Ebert's research focuses on the genetic and molecular basis of myelodysplastic syndromes and other hematologic disorders. His laboratory has identified key genetic mutations that drive the pathogenesis of MDS, including mutations in the splicing factor genes. Ebert's work has led to a better understanding of the clonal evolution of hematopoietic stem cells and the development of targeted therapies for MDS.
Contributions to Medicine[edit | edit source]
Ebert has published extensively in high-impact scientific journals and has been recognized for his contributions to the field of hematology. His research has provided insights into the mechanisms of disease progression in MDS and has influenced the development of new diagnostic and therapeutic strategies.
Awards and Honors[edit | edit source]
Ebert has received numerous awards for his research, including the William Dameshek Prize from the American Society of Hematology and the E. Mead Johnson Award from the Society for Pediatric Research.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
